| Literature DB >> 24859648 |
Janina Helle1, Kristin Kräker2, Manuela I Bader2, Annekathrin M Keiler2, Oliver Zierau2, Günter Vollmer2, JoEllen Welsh3, Georg Kretzschmar2.
Abstract
8-Prenylnaringenin (8-PN) and naringenin (Nar) are phytoestrogens found in food items and nutritional supplements, while 6-(1.1-dimethylallyl)naringenin (6-DMAN) is a component of an African plant. Besides their assumed beneficial effects they may promote mammary and endometrial cancer. We therefore assessed their proliferative and estrogenic potential on the mammary gland in vitro and in vivo. In competitive estrogen receptor (ER) ligand binding assays 8-PN displayed a high relative binding affinity for both ERs with a preference for ERα and had the strongest mitotic effect on MCF-7 cells among the test substances. In a three day exposure in young adult ovariectomized female rats 15 mg/kg 8-PN had the highest capacity to increase the number of terminal end buds (TEB) in the mammary gland and stimulated expression of proliferation markers in epithelial ductal cells, followed by 6-DMAN and Nar, but overall their capacity to stimulate proliferation was weak in comparison to 17β-Estradiol (E2).Entities:
Keywords: 6-(1.1-Dimethylallyl)naringenin; 8-Prenylnaringenin; Hormone replacement therapy; MCF-7 cells; Naringenin; Uterotrophic assay
Mesh:
Substances:
Year: 2014 PMID: 24859648 DOI: 10.1016/j.mce.2014.05.014
Source DB: PubMed Journal: Mol Cell Endocrinol ISSN: 0303-7207 Impact factor: 4.102